335810 — Precision Biosensor Income Statement
0.000.00%
- KR₩58bn
- KR₩69bn
- KR₩20bn
Annual income statement for Precision Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,205 | 8,685 | 15,887 | 20,458 | 20,391 |
Cost of Revenue | |||||
Gross Profit | 2,772 | 4,767 | 4,605 | 6,755 | 7,686 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,841 | 10,149 | 19,872 | 24,958 | 24,847 |
Operating Profit | -2,636 | -1,464 | -3,984 | -4,500 | -4,456 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -405 | -4,953 | -4,281 | -7,005 | -5,382 |
Provision for Income Taxes | |||||
Net Income After Taxes | -405 | -4,953 | -4,152 | -6,806 | -4,490 |
Net Income Before Extraordinary Items | |||||
Net Income | -405 | -4,953 | -4,152 | -6,806 | -4,490 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -405 | -4,953 | -4,152 | -6,806 | -4,490 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -48.9 | -558 | -384 | -591 | -407 |
Dividends per Share |